3-93995919-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001174150.2(ARL13B):​c.105C>T​(p.Thr35Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.008 in 1,613,128 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0071 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0081 ( 81 hom. )

Consequence

ARL13B
NM_001174150.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.91

Publications

6 publications found
Variant links:
Genes affected
ARL13B (HGNC:25419): (ADP ribosylation factor like GTPase 13B) This gene encodes a member of the ADP-ribosylation factor-like family. The encoded protein is a small GTPase that contains both N-terminal and C-terminal guanine nucleotide-binding motifs. This protein is localized in the cilia and plays a role in cilia formation and in maintenance of cilia. Mutations in this gene are the cause of Joubert syndrome 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
ARL13B Gene-Disease associations (from GenCC):
  • Joubert syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Joubert syndrome 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 3-93995919-C-T is Benign according to our data. Variant chr3-93995919-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.91 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00714 (1087/152204) while in subpopulation NFE AF = 0.00947 (644/68004). AF 95% confidence interval is 0.00886. There are 6 homozygotes in GnomAd4. There are 484 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARL13BNM_001174150.2 linkc.105C>T p.Thr35Thr synonymous_variant Exon 2 of 10 ENST00000394222.8 NP_001167621.1 Q3SXY8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARL13BENST00000394222.8 linkc.105C>T p.Thr35Thr synonymous_variant Exon 2 of 10 1 NM_001174150.2 ENSP00000377769.3 Q3SXY8-1

Frequencies

GnomAD3 genomes
AF:
0.00717
AC:
1090
AN:
152088
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00183
Gnomad AMI
AF:
0.0198
Gnomad AMR
AF:
0.00839
Gnomad ASJ
AF:
0.0435
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00947
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.00796
AC:
1997
AN:
250734
AF XY:
0.00831
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00718
Gnomad ASJ exome
AF:
0.0417
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00143
Gnomad NFE exome
AF:
0.00954
Gnomad OTH exome
AF:
0.0157
GnomAD4 exome
AF:
0.00809
AC:
11824
AN:
1460924
Hom.:
81
Cov.:
31
AF XY:
0.00806
AC XY:
5861
AN XY:
726772
show subpopulations
African (AFR)
AF:
0.00164
AC:
55
AN:
33438
American (AMR)
AF:
0.00749
AC:
335
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0406
AC:
1060
AN:
26116
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39616
South Asian (SAS)
AF:
0.00312
AC:
269
AN:
86140
European-Finnish (FIN)
AF:
0.00131
AC:
70
AN:
53378
Middle Eastern (MID)
AF:
0.0347
AC:
200
AN:
5758
European-Non Finnish (NFE)
AF:
0.00829
AC:
9211
AN:
1111438
Other (OTH)
AF:
0.0103
AC:
622
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
579
1158
1736
2315
2894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00714
AC:
1087
AN:
152204
Hom.:
6
Cov.:
32
AF XY:
0.00651
AC XY:
484
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.00183
AC:
76
AN:
41546
American (AMR)
AF:
0.00831
AC:
127
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0435
AC:
151
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4826
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10586
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00947
AC:
644
AN:
68004
Other (OTH)
AF:
0.0180
AC:
38
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00905
Hom.:
9
Bravo
AF:
0.00785
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0135
EpiControl
AF:
0.0116

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
May 29, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome 8 Benign:3
Dec 01, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARL13B: BP4, BP7, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
2.5
DANN
Benign
0.66
PhyloP100
-1.9
Mutation Taster
=296/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146396078; hg19: chr3-93714763; API